1. Antitumor activity of RT2 peptide derived from crocodile leukocyte peptide on human colon cancer xenografts in nude mice. Issue 9 (18th July 2018) Authors: Maraming, Pornsuda; Klaynongsruang, Sompong; Boonsiri, Patcharee; Maijaroen, Surachai; Daduang, Sakda; Chung, Jing‐Gung; Daduang, Jureerut Journal: Environmental toxicology Issue: Volume 33:Issue 9(2018) Page Start: 972 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Conjugation with gold nanoparticles improves the stability of the KT2 peptide and maintains its anticancer properties. Issue 1 (20th December 2021) Authors: Maraming, Pornsuda; Daduang, Jureerut; Kah, James Chen Yong Journal: RSC advances Issue: Volume 12:Issue 1(2022) Page Start: 319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. The cationic cell‐penetrating KT2 peptide promotes cell membrane defects and apoptosis with autophagy inhibition in human HCT 116 colon cancer cells. Issue 12 (9th May 2019) Authors: Maraming, Pornsuda; Klaynongsruang, Sompong; Boonsiri, Patcharee; Peng, Shu‐Fen; Daduang, Sakda; Leelayuwat, Chanvit; Pientong, Chamsai; Chung, Jing‐Gung; Daduang, Jureerut Journal: Journal of cellular physiology Issue: Volume 234:Issue 12(2019:Dec.) Page Start: 22116 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗